Apo2 ligand (Apo2L/TRAIL) is a member of the tumour necrosis factor (TNF)-cytokine family that can induce apoptosis in a variety of transformed cells, including breast cancer, whilst sparing most non-transformed cells [10]–[12]. This evidence concerns the gene TNFSF10 and breast carcinoma.